alastair gray

Dikutip oleh

	Semua	Sejak 2020
Kutipan	53548	19820
indeks-h	110	63
indeks-i10	382	260

4200

2100

1050

3150

1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025177 247 359 427 481 561 566 663 825 980 1041 1100 1340 1517 1791 2377 2553 2772 3007 3028 3100 3451 3596 3901 4130 3869 3506 766

Akses publik

Lihat semua

222 artikel

10 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Borislava MihaylovaUniversity of Oxford, Queen Mary University of LondonEmail yang diverifikasi di dph.ox.ac.uk
Philip ClarkeProfessor of health economics, university of melbourneEmail yang diverifikasi di unimelb.edu.au
david p taggartProfessor of Cardiovascular Surgery Oxford UniversityEmail yang diverifikasi di ouh.nhs.uk
Oliver Rivero-AriasAssociate Professor, University of OxfordEmail yang diverifikasi di npeu.ox.ac.uk
Marcus FlatherUniversity of East AngliaEmail yang diverifikasi di uea.ac.uk
Andrew BriggsLondon School of Hygiene & Tropical MedicineEmail yang diverifikasi di lshtm.ac.uk
Umberto BenedettoUniversity of BristolEmail yang diverifikasi di bristol.ac.uk
Helen A DakinHealth Economics Research Centre, University of Oxford, UKEmail yang diverifikasi di ndph.ox.ac.uk
Colin BaigentProfessor of Epidemiology, Oxford UniversityEmail yang diverifikasi di ctsu.ox.ac.uk
Douglas G AltmanCentre for Statistics in Medicine, University of OxfordEmail yang diverifikasi di csm.ox.ac.uk
Mike RaynerProfessor of Population Health, University of OxfordEmail yang diverifikasi di dph.ox.ac.uk
Andrew FarmerProfessor of General Practice, University of OxfordEmail yang diverifikasi di phc.ox.ac.uk
a.mcguireProfessor of Health Economics, London School of EconomicsEmail yang diverifikasi di lse.ac.uk
Andrew J CarrNuffield Professor of Orthopaedic Surgery, University of OxfordEmail yang diverifikasi di ndorms.ox.ac.uk
Ray FitzpatrickUniversity of OxfordEmail yang diverifikasi di nuffield.ox.ac.uk
David J BeardUniversity of OxfordEmail yang diverifikasi di ndorms.ox.ac.uk
Peter RothwellUniversity of OxfordEmail yang diverifikasi di clneuro.ox.ac.uk
Peter ScarboroughUniversity of OxfordEmail yang diverifikasi di phc.ox.ac.uk
Nigel ArdenUniversity of OxfordEmail yang diverifikasi di ndorms.ox.ac.uk
Kamlesh KhuntiProfessor of Primary Care Diabetes and Vascular Medicine, University of LeicesterEmail yang diverifikasi di le.ac.uk

Ikuti

alastair gray

Emeritus Professor of Health Economics, University of Oxford

Email yang diverifikasi di dph.ox.ac.uk

health economics


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials CT Trialists The Lancet 376 (9753), 1670-1681, 2010	4575*	2010
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, EH Barnes, ... Lancet (London, England) 380 (9841), 581-590, 2012	2452	2012
The economic burden of back pain in the UK N Maniadakis, A Gray Pain 84 (1), 95-103, 2000	2232	2000
Economic burden of cancer across the European Union: a population-based cost analysis R Luengo-Fernandez, J Leal, A Gray, R Sullivan The lancet oncology 14 (12), 1165-1174, 2013	1305	2013
Economic burden of cardiovascular diseases in the enlarged European Union J Leal, R Luengo-Fernández, A Gray, S Petersen, M Rayner European heart journal 27 (13), 1610-1619, 2006	1140	2006
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ... The Lancet 393 (10166), 51-60, 2019	1043	2019
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022	1035*	2022
European cardiovascular disease statistics 2012 M Nichols, N Townsend, R Luengo-Fernandez, J Leal, A Gray, ...	997	2012
Applied methods of cost-effectiveness analysis in healthcare AM Gray, PM Clarke, JL Wolstenholme, S Wordsworth OUP Oxford, 2010	890	2010
European cardiovascular disease statistics S Allender, P Scarborough, V Peto, M Rayner, J Leal, ... European Heart Network 3, 11-35, 2008	867	2008
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) PM Clarke, AM Gray, A Briggs, AJ Farmer, P Fenn, RJ Stevens, ... Diabetologia 47, 1747-1759, 2004	807	2004
Knee replacement AJ Price, A Alvand, A Troelsen, JN Katz, G Hooper, A Gray, A Carr, ... The Lancet 392 (10158), 1672-1682, 2018	775	2018
Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62) P Clarke, A Gray, R Holman Medical Decision Making 22 (4), 340-349, 2002	624	2002
Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial JN Primrose, R Perera, A Gray, P Rose, A Fuller, A Corkhill, S George, ... Jama 311 (3), 263-270, 2014	551	2014
Arthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trial DJ Beard, JL Rees, JA Cook, I Rombach, C Cooper, N Merritt, BA Shirkey, ... The Lancet 391 (10118), 329-338, 2018	522	2018
European cardiovascular disease statistics J Leal, R Luengo-Fernandez, A Gray British Heart Foundation, 2000	521	2000
UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom … AJ Hayes, J Leal, AM Gray, RR Holman, PM Clarke Diabetologia 56, 1925-1933, 2013	511	2013
Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) A Gray, M Raikou, A McGuire, P Fenn, R Stevens, C Cull, I Stratton, ... Bmj 320 (7246), 1373-1378, 2000	485	2000
Handling uncertainty when performing economic evaluation of healthcare interventions. AH Briggs, AM Gray Health technology assessment (Winchester, England) 3 (2), 1-134, 1999	474	1999
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open … PD Med Collaborative Group The Lancet 384 (9949), 1196-1205, 2014	473	2014

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama